Quest Diagnostics | 8-K: Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024
Quest Diagnostics | 8-K: Quest Diagnostics Completes Acquisition of LifeLabs,Enhancing Access to Diagnostic Innovation
Quest Diagnostics | 8-K: Quest Diagnostics Prices $1.85 Billion of Senior Notes
Quest Diagnostics | 8-K: Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics | 8-K: Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
Quest Diagnostics | 8-K: Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
Quest Diagnostics | 8-K: Poll Results of 2024 Stockholders Meeting
Quest Diagnostics | 8-K: Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
Quest Diagnostics | DEFA14A: Others
Quest Diagnostics | DEF 14A: Definitive information statements
Quest Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Quest Diagnostics | 8-K: Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
Quest Diagnostics | 8-K: Quest Diagnostics Prices $750 Million of Senior Notes
Quest Diagnostics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Quest Diagnostics | 8-K: Quest Diagnostics Reports Third Quarter 2023 Financial Results and Updates Guidance for Full Year 2023
Quest Diagnostics | 8-K: Dr. Gail R. Wilensky announces that she is relinquishing her reelection to the Board of Directors and is stepping down from the Board upon the expiration of her current term as a director
Quest Diagnostics | 8-K: Quest Diagnostics Reports Second Quarter 2023 Financial Results and Updates Guidance for Full Year 2023
Quest Diagnostics | 8-K: Voting results of the 2023 Annual General Meeting of Shareholders
Quest Diagnostics | 8-K: Quest Diagnostics Reports First Quarter 2023 Financial Results
Quest Diagnostics | DEFA14A: Others
No Data
No Data